Abstract
The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 311-329 |
| Number of pages | 19 |
| Journal | Rheumatic Disease Clinics of North America |
| Volume | 26 |
| Issue number | 2 |
| State | Published - 2000 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Rheumatology
Cite this
Steroid-induced osteoporosis in systemic lupus erythematosus. / Cunnane, G.; Lane, Nancy E.
In: Rheumatic Disease Clinics of North America, Vol. 26, No. 2, 2000, p. 311-329.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Steroid-induced osteoporosis in systemic lupus erythematosus
AU - Cunnane, G.
AU - Lane, Nancy E
PY - 2000
Y1 - 2000
N2 - The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.
AB - The patient with SLE is at considerable risk of osteoporosis, because of the inflammatory disease itself, its consequences, and its treatments. Because of their extensive use, glucocorticoids are thought to be the most frequent cause of drug-related osteoporosis and may be responsible for much of the bone loss in lupus. This article focuses on the mechanisms of steroid- induced osteoporosis in SLE and outlines strategies for prevention and treatment.
UR - http://www.scopus.com/inward/record.url?scp=0034086358&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034086358&partnerID=8YFLogxK
M3 - Article
C2 - 10768214
AN - SCOPUS:0034086358
VL - 26
SP - 311
EP - 329
JO - Rheumatic Disease Clinics of North America
JF - Rheumatic Disease Clinics of North America
SN - 0889-857X
IS - 2
ER -